- Category
- Micro (2023-24)
- Udyam number
- UDYAM-MH-20-0031100

Oribella Cosmepharm Private Limited
About Oribella Cosmepharm Private Limited
Data last updated:
Oribella Cosmepharm Private Limited is a private limited company based in Chandrapur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U74900MH2016PTC272629. Its GSTIN is 27AACCO2651G1ZL (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Abhay Radhelal Dolare and Gurudas Kalangu Giripunje.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at State Bank Officer Clony Tadoba Road Tukum, Chandrapur, Maharashtra, India – 442402.
As per the financials filed for FY 2022, the company reported a revenue of ₹14.62 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹13.02 Lakh (net margin -89%) and EBITDA of -₹12.63 Lakh (EBITDA margin -86.4%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years.
Oribella Cosmepharm Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0031100). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Oribella Cosmepharm
Contact details
Oribella Cosmepharm Private Limited's registered office is in Chandrapur, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressState Bank Officer Clony Tadoba Road Tukum, Chandrapur, Maharashtra, India – 442402
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Oribella Cosmepharm Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Oribella Cosmepharm is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Oribella Cosmepharm Private Limited, buy the company report.
Financials of Oribella Cosmepharm Private Limited
FY 2022 filings availableOribella Cosmepharm Private Limited reported revenue of ₹14.62 Lakh (up 159% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 4% over three years, including 159% growth in the latest year. EBITDA fell 366% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹12.63 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹13.02 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -86.4% | ||||
| Net Profit Margin | -89% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Oribella Cosmepharm Private Limited, buy the company report.
Board of directors of Oribella Cosmepharm Private Limited
Oribella Cosmepharm has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhay Radhelal Dolare | Director | 03 Feb 2016 | 10 Years 8 Months | Current |
| Gurudas Kalangu Giripunje | Director | 03 Feb 2016 | 10 Years 8 Months | Current |
Peer comparison
Oribella Cosmepharm Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Thameen Healthcare Private Limited | ₹14.68 Lakh (FY 2024) | 93.0% | Bangalore, Karnataka, India | |||
| Emacity Life Science Private Limited | ₹14.64 Lakh (FY 2025) | -13.0% | Neemuch, Madhya Pradesh, India | |||
| Barak Pharmaceutical Private Limited | ₹14.62 Lakh (FY 2019) | 181.0% | Mumbai, Maharashtra, India | |||
| Oribella Cosmepharm Private Limitedthis company | ₹14.62 Lakh (FY 2022) | -₹13.02 Lakh | -89% | 159.0% | Chandrapur, Maharashtra, India | |
| Herbonicz Ind Private Limited | ₹14.43 Lakh (FY 2024) | 16.0% | Chennai, Tamil Nadu, India | |||
| Elinza Pharmaceuticals Private Limited | ₹14.42 Lakh (FY 2025) | 17.0% | Chandigarh, India |
To see the full peer comparison of Oribella Cosmepharm Private Limited, buy the company report.
Auditor
Oribella Cosmepharm Private Limited is audited by M A RAHMAN & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M A RAHMAN & CO | FY 2019 | 132857W |
Shareholding
The shareholding of Oribella Cosmepharm Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Oribella Cosmepharm Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Oribella Cosmepharm Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oribella Cosmepharm Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Oribella Cosmepharm has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCO2651G1ZL | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Oribella Cosmepharm Private Limited, buy the company report.
Recent activity
Oribella Cosmepharm Private Limited has 6 board changes on record since 2016: 2 appointments and 4 cessations. The latest: Nitin Muralidhar Tonge ceased to be Director on 20 Jan 2022.
Frequently asked questions
Oribella Cosmepharm is an active private limited company based in Chandrapur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 February 2016 (10+ years old) and is registered under CIN U74900MH2016PTC272629.
Oribella Cosmepharm has 2 current directors:
- Abhay Radhelal Dolare - Director
- Gurudas Kalangu Giripunje - Director
The latest financial statements of Oribella Cosmepharm on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Oribella Cosmepharm is 27AACCO2651G1ZL, registered in Maharashtra.
The CIN (Corporate Identification Number) of Oribella Cosmepharm is U74900MH2016PTC272629. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oribella Cosmepharm was incorporated on 03 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Oribella Cosmepharm by revenue are Thameen Healthcare Private Limited, Emacity Life Science Private Limited, Barak Pharmaceutical Private Limited, Herbonicz Ind Private Limited, Elinza Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Nitin Muralidhar Tonge ceased to be Director on 20 Jan 2022. Sachin Anil Ambekar ceased to be Director on 20 Jan 2022. Mangesh Babu Mendhe ceased to be Director on 03 Nov 2018. Oribella Cosmepharm has 6 board changes on record in total.
Yes, Oribella Cosmepharm is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-20-0031100).
The registered office of Oribella Cosmepharm is at State Bank Officer Clony Tadoba Road Tukum, Chandrapur, Maharashtra, India – 442402.
Oribella Cosmepharm operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

